Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT
Valuace
30
Růst
60
Zdraví
55
Cena
$ 72.96
Dnes
--0.66 (-1.86%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
7.7B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
17%
ROA
13%
PE
42
PS
5
Cena 1R
33-117
⌀ Cena
72.31
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

Společnost Corcept Therapeutics Incorporated ve Spojených státech objevuje, vyvíjí a komercializuje léky pro léčbu závažných metabolických, onkologických a neuropsychiatrických poruch. Společnost nabízí tablety Korlym (mifepriston) jako perorální lék podávaný jednou denně k léčbě hyperglykémie navozené hyperkortikolismem u dospělých pacientů s endogenním Cushingovým syndromem, kteří trpí diabetes mellitus 2. typu nebo intolerancí glukózy a u nichž selhal chirurgický výkon nebo u nichž nelze provést chirurgický zákrok. Vyvíjí se relakorilant k léčbě pacientů s Cushingovým syndromem; a nab-paklitaxel v kombinaci s relakorilantem, který dokončil klinickou studii fáze II k léčbě pacientů s pokročilými nádory vaječníků, stejně jako k léčbě nadbytku kortizolu. Společnost také vyvíjí selektivní kortizolový modulátor pro léčbu pacientů s metastazujícím kastračně rezistentním karcinomem prostaty; selektivní kortizolový modulátor pro léčbu antipsychoticky indukovaného přibývání na váze a dalších poruch; a testy genové exprese FKBP5. Společnost Corcept Therapeutics Incorporated byla založena v roce 1998 a sídlí v Menlo Parku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
500
Založení
2004-04-14
Adresa
149 Commonwealth Drive
CEO
Joseph K. Belanoff
Web
www.corcept.com

Podobné společnosti

HALO
Halozyme Therapeutics, Inc.
$ 68.88
+ $ 0.64
RYTM
Rhythm Pharmaceuticals, Inc.
$ 96.93
- $ 3.37
MRUS
Merus N.V.
$ 95.23
- $ 0.01
CYTK
Cytokinetics, Incorporated
$ 61.81
+ $ 1.65
JAZZ
Jazz Pharmaceuticals plc
$ 132.79
+ $ 1.63
AXSM
Axsome Therapeutics, Inc.
$ 137.94
- $ 0.21
NUVL
Nuvalent, Inc.
$ 91.82
- $ 1.54

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues761.4761.4675.0482.4401.9366.0353.9306.5251.2159.281.350.326.610.43.30.00.0
Cost of Revenues13.013.010.96.55.45.35.65.55.23.62.11.40.90.10.10.00.0
Gross Profit748.4748.4664.2475.9396.5360.7348.3301.0246.0155.679.348.925.710.23.20.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues202.1207.6194.4157.2181.9182.5163.8146.8135.4123.6
Cost of Revenues2.54.63.42.43.02.92.52.51.91.6
Gross Profit199.6203.0191.0154.8178.9179.7161.3144.3133.5122.0
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0184.4131.0113.9114.889.075.240.423.815.418.420.514.121.018.9
Selling General & Admin Expenses0.00.00.0184.3152.8122.4105.3100.481.362.445.236.934.931.225.411.38.5
Depreciation & Amortization1.91.91.31.03.03.12.22.20.20.10.10.20.10.10.00.00.0
Total Operating Expenses703.6703.6527.2368.6283.8236.2220.1189.4156.5102.869.152.453.351.739.532.327.4
Operating Income44.844.8137.0107.3112.6124.5128.2111.689.552.910.2-3.4-27.6-41.5-36.3-32.3-27.4
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.054.745.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.047.245.3
Depreciation & Amortization0.50.50.50.50.50.50.30.10.60.2
Total Operating Expenses195.1192.8164.3151.4153.7133.1125.7114.8101.990.8
Operating Income4.510.226.73.425.346.635.629.531.731.2
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income32.50.024.517.33.60.53.45.12.70.00.00.00.00.00.00.00.0
Interest Expense0.00.00.00.03.60.00.05.12.70.02.03.03.84.51.80.01.5
Other Expense21.721.724.517.33.60.53.45.12.70.0-2.0-3.0-3.8-4.5-1.80.00.0
IBT66.566.5161.5124.6116.2125.0131.6116.792.252.88.1-6.4-31.4-46.0-38.0-32.4-26.0
Income Tax Expense-24.3-33.220.318.414.812.525.622.516.7-76.30.00.00.00.00.00.0-1.5
Net Income99.199.7139.7106.1101.4112.5106.094.275.4129.18.1-6.4-31.4-46.0-38.0-32.4-26.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income16.25.05.06.26.76.36.05.55.15.2
Interest Expense0.00.00.00.00.00.00.00.03.60.0
Other Expense5.45.05.06.26.76.36.05.55.15.2
IBT9.915.231.79.632.052.941.635.036.836.4
Income Tax Expense-14.44.4-3.5-10.91.25.76.17.25.55.0
Net Income24.319.435.120.330.446.735.527.831.431.4
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$1.02$0.95$0.97$0.92$0.82$0.65$1.14$0.07$-0.06$-0.31$-0.46$-0.41$-0.39$-0.38
EPS Diluted$0.00$0.00$0.00$0.94$0.87$0.89$0.85$0.77$0.60$1.04$0.07$-0.06$-0.31$-0.46$-0.41$-0.39$-0.38
Shares Outstanding103.9103.9103.2103.6106.8115.7115.4114.3115.3113.5110.6106.9101.099.893.083.368.3
Diluted Shares Outstanding119.9120.0113.5111.7116.0126.0124.2122.6126.7124.5116.1106.9101.099.893.083.368.3
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.30$0.31
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.28$0.28
Shares Outstanding103.9103.5104.1104.1103.6103.4103.1102.8102.5102.0
Diluted Shares Outstanding119.9119.4120.5119.8118.5113.7111.2109.9110.9111.1
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents128.6127.7135.6436.6335.8476.9315.3206.8104.051.540.424.254.993.039.624.6
Short Term Investments344.6255.7232.7365.3145.9364.5244.7165.157.70.00.00.00.00.00.00.0
Total Cash & ST Investments473.2383.3368.2436.6335.8476.9315.3206.8104.051.540.424.254.993.039.624.6
Accounts Receivable56.158.141.145.127.626.219.917.628.29.96.23.31.40.60.00.0
Inventory8.412.47.717.018.021.217.416.28.42.31.71.21.10.90.00.0
Other Current Assets23.217.841.616.410.36.76.07.72.72.00.61.40.90.60.10.4
Total Current Assets560.8471.6458.6498.7381.4524.2352.6240.6140.665.749.030.258.395.139.825.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents125.1102.789.8127.7137.3128.6149.8135.6111.8172.4
Short Term Investments296.5239.5232.9255.7243.0344.6261.0232.7243.4190.9
Total Cash & ST Investments421.7342.2322.8383.3380.3473.2410.8368.2355.2363.3
Accounts Receivable73.568.784.458.162.656.163.541.134.632.6
Inventory12.312.314.412.48.18.47.27.77.56.9
Other Current Assets33.619.917.017.816.023.221.967.453.045.1
Total Current Assets541.1443.1438.5471.6467.0560.8503.4458.6431.5432.6
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment7.28.00.31.10.52.53.40.70.50.20.10.20.20.20.00.0
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments19.3219.857.24.9112.336.239.40.015.30.00.00.00.00.00.00.0
Other Long-Term Assets15.410.214.817.214.413.410.57.83.22.92.94.24.64.00.00.1
Total Long-Term Assets153.7369.0162.984.742.447.559.771.179.93.13.04.44.84.10.10.1
Total Assets714.6840.6621.5583.4423.8571.7412.3311.7220.568.851.934.663.199.239.825.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment6.97.37.78.08.47.20.20.30.50.6
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments102.6172.8248.0219.8167.319.340.357.259.60.0
Other Long-Term Assets20.116.37.810.214.715.414.214.815.313.2
Total Long-Term Assets282.5358.6408.0369.0317.3153.7152.6162.9162.592.0
Total Assets823.6801.7846.5840.6784.3714.6655.9621.5594.0524.6
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable19.515.417.412.06.910.67.58.38.62.31.31.92.43.83.60.8
Short-Term Debt0.00.80.31.10.52.13.50.00.014.715.09.45.72.70.00.0
Other Current Liabilities49.6124.465.468.5-0.5-2.130.127.521.00.34.42.24.61.91.43.0
Current Liabilities100.8140.8104.581.66.910.641.135.829.627.420.913.612.78.45.03.9
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable34.423.527.915.418.619.512.617.416.78.0
Short-Term Debt1.11.01.00.80.40.00.10.30.50.6
Other Current Liabilities136.8120.199.9124.4107.281.270.165.473.563.7
Current Liabilities172.3144.7143.1140.8126.2100.897.2104.5121.993.1
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt5.66.10.01.10.52.61.90.00.00.012.624.529.329.00.00.0
Capital Leases5.66.90.21.10.52.63.50.00.00.012.624.529.329.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities118.3161.0114.881.648.048.441.135.829.627.433.438.042.137.45.03.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt5.35.65.96.16.45.60.00.00.00.0
Capital Leases0.06.66.86.96.85.70.10.20.20.3
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities191.7165.9163.2161.0145.4118.3108.1114.8132.3103.0
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1
Retained Earnings465.8543.7402.5296.4195.082.5-23.6-117.7-193.1-322.3-330.4-324.0-292.6-246.6-208.6-176.2
Comprehensive Income0.1-0.20.6-0.9-0.20.40.3-0.1-0.1-0.5-0.4-0.3-0.1-0.1-0.10.0
Total Common Equity596.2679.6506.7501.8375.8523.3371.2275.9191.041.418.5-3.421.061.834.821.2
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings619.1599.4564.3543.7513.0465.8430.3402.5371.2339.8
Comprehensive Income2.32.30.7-0.21.60.10.30.6-0.20.0
Total Common Equity631.9635.8683.3679.6638.8596.2547.9506.7461.7421.6
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt5.76.90.21.10.52.63.50.00.014.715.09.45.72.70.00.0
Book Value596.2679.6506.7501.8375.8523.3371.2275.9191.041.418.5-3.421.061.834.821.2
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value631.9635.8683.3679.6638.8596.2547.9506.7461.7421.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income125.498.2141.2106.1101.4112.5106.094.275.4129.18.1-6.4-31.4-46.0-38.0-32.4-26.0
Depreciation & Amortization1.21.91.32.43.03.12.22.20.20.10.10.20.10.10.00.00.0
Stock-Based Compensation54.484.561.448.942.442.933.529.323.713.47.16.05.25.25.33.42.1
Change Working Capital-12.3-27.645.38.26.0-0.1-5.4-4.73.9-5.71.20.5-5.0-0.8-5.01.51.6
Change In Accounts Receivable-7.3-5.81.1-10.1-3.4-1.4-6.3-2.3-2.3-5.4-3.6-2.9-1.9-0.9-0.60.00.0
Change In Accounts Payable11.325.1-2.25.84.8-3.63.2-0.7-0.46.31.0-0.6-0.5-1.40.22.8-0.5
Change In Inventories-0.9-7.50.31.31.23.4-3.5-1.0-7.8-2.3-0.70.80.2-0.9-4.70.00.0
Other Non-cash Items15.7-15.0-10.9-9.11.45.11.5-1.7-1.70.82.02.93.74.41.70.00.0
Cash from Operations123.70.00.0127.0120.3167.9152.0136.1115.760.918.43.1-27.4-37.1-36.0-27.4-22.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income98.219.435.120.530.446.735.127.831.431.4
Depreciation & Amortization0.50.50.50.50.50.50.30.20.60.2
Stock-Based Compensation-63.70.019.021.816.80.00.013.213.112.9
Change Working Capital2.13.38.4-22.317.328.17.3-7.4-32.320.1
Change In Accounts Receivable9.8-5.1-2.7-7.85.7-5.97.7-6.4-6.5-2.1
Change In Accounts Payable6.010.9-4.812.9-3.9-0.16.6-4.91.08.6
Change In Inventories0.5-3.9-4.60.6-0.11.1-1.71.00.3-0.5
Other Non-cash Items1.422.2-1.3-1.7-1.813.812.5-2.9-3.2-2.8
Cash from Operations0.00.00.00.00.00.00.00.05.952.9
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.5-0.2-2.2-0.1-0.4-0.5-1.2-1.1-0.3-0.4-0.20.0-0.2-0.1-0.20.00.0
Acquisitions109.50.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Investments-460.5-319.6-588.3-328.7-355.1-312.8-420.1-299.0-233.1-73.00.00.00.00.00.00.00.0
Sales of Investment299.3389.6412.9419.8241.2449.4302.1182.3142.70.00.00.00.00.00.00.00.0
Other Investing Activities-161.20.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Cash from Investing-161.70.00.090.9-114.3136.1-119.3-117.8-90.8-73.5-0.20.0-0.2-0.1-0.20.00.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.10.0-0.1-0.1-0.1-1.6-0.40.00.00.0
Acquisitions0.00.00.00.00.00.00.00.00.0109.5
Investments-143.8-37.4-23.3-115.1-144.6-223.1-142.7-77.9-29.9-210.0
Sales of Investment132.052.093.5112.180.3180.783.068.947.0100.5
Other Investing Activities0.00.00.00.00.00.00.00.017.1-109.5
Cash from Investing0.00.00.00.00.00.00.00.017.1-109.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-1.30.00.00.00.00.00.00.00.0-15.1-14.8-9.2-4.9-1.00.00.00.0
Debt Issued6.76.96.8-1.00.6-2.0-0.93.50.00.514.514.78.54.12.70.00.0
Issuance of Common Stock10.50.00.05.84.40.00.00.00.00.00.00.00.00.159.742.523.0
Repurchase of Common Stock-154.4-245.9-15.7-145.40.0-296.0-9.9-31.0-23.70.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities145.80.00.0-9.1-21.7-6.622.22.39.37.27.722.31.80.029.90.00.0
Cash from Financing-5.80.00.0-148.7-17.3-302.612.2-28.6-14.3-8.0-7.113.1-3.1-1.089.642.523.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued6.4-0.2-0.2-0.10.11.15.6-0.1-0.1-0.1
Issuance of Common Stock0.00.00.00.00.00.00.00.04.41.1
Repurchase of Common Stock-36.5-42.5-103.00.00.0-11.7-3.50.0-145.4-5.1
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.81.1
Cash from Financing0.00.00.00.00.00.00.00.00.8-3.9
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-43.8-7.2-7.969.2-11.31.444.9-10.410.6-20.511.116.2-30.6-38.253.415.10.7
Closing Cash Balance128.6120.5127.7135.666.377.676.231.341.631.151.540.424.254.993.039.624.6
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-4.622.412.9-37.8-9.68.7-21.214.223.8-60.6
Closing Cash Balance120.5125.1102.789.8127.7137.3128.6149.8135.6111.8
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow123.3141.8195.9126.9119.9167.4150.7135.0115.460.518.23.1-27.6-37.2-36.2-27.4-22.3
Real Free Cash Flow68.957.3134.578.077.5124.5117.2105.791.647.211.1-2.9-32.8-42.4-41.5-30.9-24.4
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow38.454.543.95.059.272.240.823.85.952.9
Real Free Cash Flow102.154.524.9-16.842.472.240.810.5-7.240.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E41.921-1.4
P/S5.5179.4
P/B6.67.55.2
P/FCF25.223.7-1.5
Market cap$7.7$4.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.8 %6.3 %0 %
Debt to Income6.4 %11.9 %0 %
Debt to Free cash flow3.9 %3230.1 %0 %
Interest expense percentage0 %2.4 %44.7 %
Current ratio3.1 8.5 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE15.7 %19.6 %0 %
ROA12 %-9.9 %0 %
CapEx to Revenue0 %0.6 %0 %
RaD to Revenue0 %95.1 %0 %
ROEM1,522,814.0 723092.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin98.2 %83.7 %68.7 %
Operating margin8.8 %-148.5 %35.5 %
Net margin14.2 %-154.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding119.4 mil 109.3 mil
Employee count0.5 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader